Literature DB >> 7522365

Nitric oxide generation. A predictive parameter of acute allograft rejection.

J Devlin1, R M Palmer, C E Gonde, J O'Grady, N Heaton, K C Tan, J F Martin, S Moncada, R Williams.   

Abstract

The L-arginine:nitric oxide (NO) biosynthetic pathway has been proposed as an important mediator in host defense mechanisms and may therefore play a role in the acute allograft response. We have studied NO generation in liver allograft rejection and determined its value in immunological monitoring. Stable end products of this pathway have been determined serially in 50 primary liver recipients and compared with 2 known mediators and markers of acute allograft rejection (IL-2R positive lymphocytes and circulating TNF alpha). Plasma concentrations of acid-labile nitrosocompounds (NOx), which increased during acute allograft rejection (P < 0.0001), correlated with rejection severity and were reduced after administration of supplemental high dose glucocorticoids. Concentrations were significantly lower in nonrejection graft complications but were elevated during episodes of sepsis. Correlations between plasma NOx levels and circulating TNF-alpha (r = 0.451, P < 0.001) and IL-2R-positive lymphocytes in peripheral blood (r = 0.781, P < 0.001) were demonstrated. In a logistic analysis of these variables, plasma NOx was the most predictive parameter of an episode of acute cellular rejection. Nitric oxide generation in FK506-treated patients was lower compared with patients receiving a CsA-based immunosuppression regimen and was associated with a reduced frequency of acute rejection in the FK506 group. These data are consistent with a role for NO in the cellular alloantigen immune response and indicate that monitoring of plasma levels of NOx may be useful in the detection of acute allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522365

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  10 in total

1.  Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.

Authors:  L L Shears; N Kawaharada; E Tzeng; T R Billiar; S C Watkins; I Kovesdi; A Lizonova; S M Pham
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Analysis of the in vitro effect of exogenous nitric oxide on human lymphocytes.

Authors:  A S Shoker; H Yang; M A Murabit; H Jamil; A al-Ghoul; K Okasha
Journal:  Mol Cell Biochem       Date:  1997-06       Impact factor: 3.396

3.  Nitric oxide level profile in human liver transplantation.

Authors:  Stefania Battista; Giulio Mengozzi; Fabrizio Bar; Elisabetta Cerutti; Cristina Pollet; Mauro Torchio; Fiorella Biasi; Guido Cavalli; Mauro Salizzoni; Giuseppe Poli; Gianpaolo Molino
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

4.  Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock.

Authors:  F Squadrito; D Altavilla; G Squadrito; M Ferlito; G M Campo; M Arlotta; S Grimaldi; C Quartarone; A Saitta; A P Caputi
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

5.  TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury.

Authors:  J Muntané; F J Rodríguez; O Segado; A Quintero; J M Lozano; E Siendones; C A Pedraza; M Delgado; F O'Valle; R García; J L Montero; M De La Mata; G Miño
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

6.  Differential localization of allograft nitric oxide synthesis: comparison of liver and heart transplantation in the rat model.

Authors:  P C Kuo; E J Alfrey; N R Krieger; K Y Abe; P Huie; R K Sibley; D C Dafoe
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

7.  Nitric oxide inhibits INFgamma-induced increases in CIITA mRNA abundance and activation of CIITA dependent genes--class II MHC, Ii and H-2M. Class II TransActivator.

Authors:  M L Kielar; S C Sicher; J G Penfield; D R Jeyarajah; C Y Lu
Journal:  Inflammation       Date:  2000-10       Impact factor: 4.092

8.  Cross sectional study of exhaled nitric oxide levels following lung transplantation.

Authors:  A J Fisher; E Gabbay; T Small; S Doig; J H Dark; P A Corris
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

9.  Diagnostic Biomarkers to Diagnose Acute Allograft Rejection After Liver Transplantation: Systematic Review and Meta-Analysis of Diagnostic Accuracy Studies.

Authors:  Felix Krenzien; Eriselda Keshi; Katrin Splith; Silvan Griesel; Kaan Kamali; Igor M Sauer; Linda Feldbrügge; Johann Pratschke; Annekatrin Leder; Moritz Schmelzle
Journal:  Front Immunol       Date:  2019-04-11       Impact factor: 7.561

10.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.

Authors:  G Melillo; T Musso; A Sica; L S Taylor; G W Cox; L Varesio
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.